1. Stander H, Cadden B. Acute yellow atrophy of the liver in pregnancy. Am J Obstet Gynecol. 1934; 28: 61–69.
2. Sheehan HL. The pathology of acute yellow atrophy and delayed chloroform poisoning. J Obstet Gynaecol Br Emp. 1940; 47: 49–62.
3. Knox TA, Olans LB. Liver disease in pregnancy. N Engl J Med. 1996; 335: 569–576.
4. Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999; 181: 389–395.
5. Knight M, Nelson-Piercy C, Kurinczuk J, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008; 57: 951–956.
6. Buytaert IM, Elewaut GP, Van Kets HE. Early occurrence of acute fatty liver in pregnancy. Am J Gastroenterol. 1996; 91: 603–604.
7. Mjahed K, Charra B, Hamoudi D, et al. Acute fatty liver of pregnancy. Arch Gynecol Obstet. 2006; 274: 349–353.
8. Bahloul M, Dammak H, Khlaf-Bouaziz N, et al. Acute fatty liver of pregnancy. About 22 cases. Gynecol Obstet Fertil. 2006; 34: 597–606.
9. Dekker R, Schutte JM, Stekelenburg J, et al. Maternal mortality and severe maternal morbidity from acute fatty liver of pregnancy in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011; 157: 27–31.
10. Reyes H, Sandoval L, Wainstein A, et al. Acute fatty liver of pregnancy: a clinical study of 12 episodes in 11 patients. Gut. 1994; 35: 101–106.
11. Usta IM, Barton JR, Gonzalez A, et al. Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gyynecol. 1994; 171: 1342–1347.
12. Mabie WC. Obstetric management of gastroenterologic complications of pregnancy. Gastroenterol Clin North Am. 1992; 21: 923–935.
13. Schoeman MN, Batey RG, Wilcken B. Recurrent acute fatty liver of pregnancy associated with a fatty acid oxidation defect in the offspring. Gastroenterology. 1991; 100: 544–548.
14. Wilcken B, Leung KC, Hammond J, et al. Pregnancy and fetal long chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet. 1993; 341: 407–408.
15. Lee N, Brady C. Liver disease in pregnancy. World J Gastroenterol. 2009; 15: 897–906.
16. Jackson S, Kler RS, Bartlett K, et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest. 1992; 90: 1219–1225.
17. Wanders RJ, IJlst L, van Gennip AH, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation. J Inherit Metab Dis. 1990; 13: 311–314.
18. Innes AM, Seargeant LE, Balachandra K, et al. Hepatic carnitine palmitoylotransferase I deficiency presenting as maternal illness in pregnancy. Pediatrc Res. 2000; 41: 43–45.
19. Matern D, Hart P, Murtha AP, et al. Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. J Pediatr. 2001; 138: 585–588.
20. Ibdah JA, Bennett MJ, Rinaldo P, et al. A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med. 1999; 340: 1723–1731.
21. Natarajan SK, Thangaraj KR, Eapen CA, et al. Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology. 2010; 51: 191–200.
22. Rakheja D, Bennett MJ, Foster BM, et al. Evidence for fatty acid oxidation in human placenta, and the relationship of fatty acid oxidation enzyme activities with gestational age. Placenta. 2002; 23: 447–450.
23. Shekhawat P, Bennett MJ, Sadovsky Y, et al. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases. Am J Physiol Endocrinol Metab. 2003; 284: E1098–E1105.
24. Natarajan SK, Eapen CE, Pullimood AB, et al. Oxidative stress in experimental liver microvesicular steatosis: role of mitochondria and peroxisomes. J Gastroenterol Hepatol. 2006; 21: 1240–1249.
25. Wang Y, Walsh SW. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998; 19: 581–586.
26. Dani R, Mendes GS, Medeiros Jde L, et al. Study of the liver changes occurring in preeclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. Am J Gastroenterol. 1996; 91: 292–294.
27. Mannaerts GP, Debeer LJ, Thomas J, et al. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. J Biol Chem. 1979; 254: 4585–4595.
28. Hashimoto T, Fujita T, Usuda N, et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisomes proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem. 1999; 274: 19228–19236.
29. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996; 271: C1424–C1437.
30. Cocco T, Di Paola M, Papa S, et al. Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation. Free Radic Biol Med. 1999; 27: 51–59.
31. Fesenmeier MF, Coppage KH, Lambers DS, et al. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol. 2005; 192: 1416–1419.
32. Riely CA. Acute fatty liver of pregnancy. Semin Liver Dis. 1987; 7: 47–54.
33. Usta IM, Barton JR, Amon EA, et al. Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol. 1994; 171: 1342–1347.
34. Rolfes DB, Ishak KG. Acute fatty liver of pregnancy; a clinicopathologic study of 35 cases. Hepatology. 1985; 5: 1149–1158.
35. Kaplan MM. Acute fatty liver of pregnancy. N Engl J Med. 1985; 313: 367–370.
36. Castro MA, Goodwin TM, Shaw KJ. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol. 1996; 174: 211–216.
37. Pereira SP, O’Donohue J, Wendon J, et al. Maternal and perinatal outcome in severe pregnancy-related liver disease. Hepatology. 1997; 26: 1258–1262.
38. Moldenhauer JS, O’Brien JM, Barton JR, et al. Acute fatty liver of pregnancy associated with pancreatitis: a life threatening complication. Am J Obstet Gynecol. 2004; 190: 502–505.
39. Kirkland EB, Sachdev R, Kim J, et al. Early pancreatic panniculitis associated with HELLP syndrome and acute fatty liver of pregnancy. J Cutan Pathol. 2011; 38: 814–817.
40. Kennedy S, Hall PM, Seymour AE, et al. Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol. 1994; 101: 387–391.
41. Hay JE. Liver disease in pregnancy. Hepatology. 2008; 47: 1067–1076.
42. Eguchi S, Yanaga K, Fujita F, et al. Living-related right lobe liver transplantation for a patient with fulminant hepatic failure during the second trimester of pregnancy: report of a case. Transplantation. 2002; 73: 1970–1971.
43. Koenen SV, Huisjes AJ, Dings J, et al. Is there a diurnal pattern in the clinical symptoms of HELLP syndrome? J Matern Fetal Neonatal Med. 2006; 19: 93–99.
44. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009; 9: 8
45. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): how much to do about nothing? Am J Obstet Gynecol. 1990; 162: 311–316.
46. Sibai BM. Imitators of severe pre-eclampsia/eclampsia. Clin Perinatol. 2004; 31: 835–852.
47. Steingrub JS. Pregnancy-associated severe liver dysfunction. Crit Care Clin. 2004; 20: 763–776.
48. Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet. 2010; 375: 594–605.
49. Saygan-Karamursel B, Kizilkilic-Parlakgumus A, Daren O, et al. Acute fatty liver of pregnancy after aspirin intake. J Matern Fetal Neonatal Med. 2004; 16: 65–66.
50. Vigil de Gracia P, Montufar-Rueda C. Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases. J Matern Fetal Neonatal Med. 2011; 24: 1143–1146.
51. Douvres PA, Rosenthal WS, Metzger P, et al. Acute fatty liver of pregnancy with hepatic coma and Mallory Weiss syndrome: report of a case. Am J Dig Dis. 1965; 10: 306–313.
52. Schorr-Losnich B, Lebovics E, Dworkin B, et al. Liver diseases unique to pregnancy. Am J Gastroenterol. 1991; 86: 659–670.
53. Vanlak D, Moreau R, Roche-Sicot J, et al. Intrahepatic cholestasis of pregnancy and acute fatty liver of pregnancy. An unusual but favorable association. Gastroenterology. 1991; 100: 1123–1125.
54. Wei Q, Zhang L, Liu X. Clinical diagnosis and treatment of acute fatty liver of pregnancy: a literature review and 11 new cases. JjObstet Gynaecol Res. 2010; 36: 751–756.
55. Gregory TL, Hughes S, Coleman MA, et al. Acute fatty liver of pregnancy; three cases and discussion of analgesia and anesthesia. Int J Obstet Anesth. 2007; 16: 175–179.
56. Leonard JV, Dezateux C. Newborn screening for medium chain acyl CoA dehydrogenase deficiency. Arch Dis Child. 2009; 94: 235–238.
57. Amon E, Allen SR, Petri RH, et al. Acute fatty liver of pregnancy associated with preeclampsia: management of hepatic failure with postpartum liver transplantation. Am J Perinatol. 1991; 8: 278–279.
58. Ockner SA, Brunt EM, Cohn SM, et al. Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology. 1990; 11: 59–64.
59. Remiszewski P, Pawlak J, Skwarek A, et al. Orthotopic liver transplantation for acute liver failure resulting from “acute fatty liver of pregnancy.”. Ann Transpl. 2003; 8: 8–11.
60. Shames BD, Fernandez LA, Sollinger HW, et al. Liver transplantation for HELLP syndrome. Liver Transpl. 2005; 11: 224–228.
61. Westbrook RH, Yeoman AD, Joshi D, et al. Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transpl. 2010; 10: 2520–2526.
62. Franco J, Newcomer J, Adams M, et al. Auxiliary liver transplant in acute fatty liver of pregnancy. Obstet Gynecol. 2000; 95: 1042